Related Experiment Video
Updated: Mar 8, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human Papillomavirus and the HPV Vaccine: Where Are We Today?
Abstract:
Vaccine discussions are an important part of the general pediatrician's day. The human papillomavirus (HPV) vaccine, in particular, has been slow to gain acceptance by the general public. It has recently gained momentum (both positive and negative) on social media, which has led to an increase in questions and concerns from families. It is important that providers are equipped to address these concerns, answer questions, and provide quality information for families to help guide them in their vaccination decisions. Not only is it crucial to be knowledgeable about the vaccines themselves, but providers should also be informed about HPV and its potential disease burden. The HPV vaccine recommendations are also evolving, so it is important to stay abreast with current data to provide the best care for all patients. [Pediatr Ann. 2017;46(1):e2-e5.].
More Related Videos
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Sexually Transmitted Infections
Cancer Prevention
Some...

